Home |  English version |  Mappa |  Commenti |  Sondaggio |  Staff |  Contattaci Cerca nel sito  
Istituto di scienza dell'alimentazione

Torna all'elenco Contributi in rivista anno 2016

Contributo in rivista

Tipo: Articolo in rivista

Titolo: Interaction of human chymase with ginkgolides, terpene trilactones of Ginkgo biloba investigated by molecular docking simulations

Anno di pubblicazione: 2016

Formato: Elettronico Cartaceo

Autori: Dubey A.; Marabotti A.; Ramteke P.W.; Facchiano A.

Affiliazioni autori: Istituto di Scienze dell'Alimentazione - CNR, Via Roma 64, Avellino, 83100, Italy; Jacob School of Biotechnology and Bioengineering, Sam Higginbottom Institute of Agriculture Technology and Sciences, Allahabad, 211007, India; Dipartimento di Chimica e Biologia Adolfo Zambelli, UniversitÓ degli Studi di Salerno, Via Giovanni Paolo II 132, Fisciano, SA, 84084, Italy

Autori CNR:


Lingua: inglese

Abstract: The search for natural chymase inhibitors has a good potential to provide a novel therapeutic approach against the cardiovascular diseases and other heart ailments. We selected from literature 20 promising Ginkgo biloba compounds, and tested them for their potential ability to bind chymase enzyme using docking and a deep analysis of surface pocket features. Docking results indicated that the compounds may interact with the active site of human chymase, with favorable distinct interactions with important residues Lys40, His57, Lys192, Phe191, Val146, Ser218, Gly216, and Ser195. In particular, proanthocyanidin is the one with the best-predicted binding energy, with seven hydrogen bonds. Interestingly, all active G. biloba compounds have formed the hydrogen bond interactions with the positively charged Lys192 residue at the active site, involved in the mechanism of pH enhancement for the cleavage of angiotensin I site. Ginkgolic acid and proanthocyanidin have better predicted binding energy towards chymase than other serine proteases, i.e kallikrein, tryptase and elastase, suggesting specificity for chymase inhibition. Our study suggests these G. biloba compounds are a promising starting point for developing chymase inhibitors for the potential development of future drugs.

Lingua abstract: inglese

Pagine da: 449

Pagine a: 454


Biochemical and biophysical research communications Elsevier [etc.]
Paese di pubblicazione: Stati Uniti d'America
Lingua: inglese
ISSN: 0006-291X

Numero volume: 473

Numero fascicolo: 2

DOI: 10.1016/j.bbrc.2016.03.028

Stato della pubblicazione: Published version

Indicizzato da: Scopus [2-s2.0-84961233803]

Parole chiave:

  • Cardiovascular diseases
  • Chymase
  • Ginkgo biloba
  • Herbal nutraceutical
  • Inhibitor
  • Molecular docking
  • Screening

URL: http://www.scopus.com/inward/record.url?eid=2-s2.0-84961233803&partnerID=q2rCbXpz

Strutture CNR:


Torna indietro Richiedi modifiche Invia per email Stampa
Home Il CNR  |  I servizi News |   Eventi | Istituti |  Focus